| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |